Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gulnar Hafiz

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
American Journal of Ophthalmology|September 25, 2017
ReplyPeter A Campochiaro, Tahreem A Mir, Yong S Han, et al.
American Journal of Ophthalmology|April 11, 2017
Increased Frequency of Topical Steroids Provides Benefit in Patients With Recalcitrant Postsurgical Macular EdemaPeter A Campochiaro, Yong S Han, Tahreem A Mir, et al.
American Journal of Ophthalmology|December 7, 2007
Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, Gulnar Hafiz, et al.
Ophthalmology|July 16, 2010
Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomesPeter A Campochiaro, Gulnar Hafiz, Roomasa Channa, et al.
Ophthalmology|March 6, 2010
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insertPeter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, et al.
Ophthalmology|December 11, 2012
Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implantsPeter A Campochiaro, Quan Dong Nguyen, Gulnar Hafiz, et al.
American Journal of Ophthalmology|September 24, 2013
Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusionRaafay Sophie, Gulnar Hafiz, Adrienne W Scott, et al.
BMC Pharmacology & Toxicology|January 16, 2013
Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin A-4 phosphateMohamed A Ibrahim, Diana V Do, Yasir J Sepah, et al.
Ophthalmology|May 15, 2015
Scatter Photocoagulation Does Not Reduce Macular Edema or Treatment Burden in Patients with Retinal Vein Occlusion: The RELATE TrialPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
Ophthalmology|April 24, 2016
ReplyPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
American Journal of Ophthalmology|September 25, 2017
ReplyPeter A Campochiaro, Tahreem A Mir, Yong S Han, et al.
American Journal of Ophthalmology|April 11, 2017
Increased Frequency of Topical Steroids Provides Benefit in Patients With Recalcitrant Postsurgical Macular EdemaPeter A Campochiaro, Yong S Han, Tahreem A Mir, et al.
American Journal of Ophthalmology|December 7, 2007
Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, Gulnar Hafiz, et al.
Ophthalmology|July 16, 2010
Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomesPeter A Campochiaro, Gulnar Hafiz, Roomasa Channa, et al.
Ophthalmology|March 6, 2010
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insertPeter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, et al.
Ophthalmology|December 11, 2012
Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implantsPeter A Campochiaro, Quan Dong Nguyen, Gulnar Hafiz, et al.
American Journal of Ophthalmology|September 24, 2013
Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusionRaafay Sophie, Gulnar Hafiz, Adrienne W Scott, et al.
BMC Pharmacology & Toxicology|January 16, 2013
Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin A-4 phosphateMohamed A Ibrahim, Diana V Do, Yasir J Sepah, et al.
Ophthalmology|May 15, 2015
Scatter Photocoagulation Does Not Reduce Macular Edema or Treatment Burden in Patients with Retinal Vein Occlusion: The RELATE TrialPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
Ophthalmology|April 24, 2016
ReplyPeter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, et al.
Pageof 3